Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYGN - Dynagen -- Ignore unavailable to you. Want to Upgrade?

To: Web2 who wrote (430)	3/4/2000 2:10:00 PM
From: Tadsamillionaire	Respond to of 444

My guess is that the CEO is on another road show, and with the Bank of Boston Financing in place plus the order from the Veteran administration.. It's an out pouring of good news. You should also factor in that Biotechs are hot, there are patents expiring on about 8 drugs that can now be made in generic form and Dynagen with Able Labs have the infa structure and sales force to accomodate those that want generics. JMHO. I am long the stock.